Global Pandemic Influenza Vaccine Market Insights and Forecast to 2031

Report ID: 1538403 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Pandemic Influenza Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Whole Virus Vaccines
        1.2.3 Split Virus Vaccines
        1.2.4 Subunit Vaccines
    1.3 Market by Application
        1.3.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 For Children (6 months to 3 years)
        1.3.3 For Adults and Children over 3 years
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Pandemic Influenza Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Pandemic Influenza Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Pandemic Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Pandemic Influenza Vaccine Sales by Region
        2.4.1 Global Pandemic Influenza Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Pandemic Influenza Vaccine by Region (2023-2028)
    2.5 Global Pandemic Influenza Vaccine Revenue by Region
        2.5.1 Global Pandemic Influenza Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Pandemic Influenza Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Pandemic Influenza Vaccine Sales by Manufacturers
        3.1.1 Global Top Pandemic Influenza Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pandemic Influenza Vaccine in 2021
    3.2 Global Pandemic Influenza Vaccine Revenue by Manufacturers
        3.2.1 Global Pandemic Influenza Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Pandemic Influenza Vaccine Revenue in 2021
    3.3 Global Pandemic Influenza Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Pandemic Influenza Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Pandemic Influenza Vaccine Sales by Type
        4.1.1 Global Pandemic Influenza Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Pandemic Influenza Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Pandemic Influenza Vaccine Revenue by Type
        4.2.1 Global Pandemic Influenza Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Pandemic Influenza Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Pandemic Influenza Vaccine Price by Type
        4.3.1 Global Pandemic Influenza Vaccine Price by Type (2017-2022)
        4.3.2 Global Pandemic Influenza Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Pandemic Influenza Vaccine Sales by Application
        5.1.1 Global Pandemic Influenza Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Pandemic Influenza Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Pandemic Influenza Vaccine Revenue by Application
        5.2.1 Global Pandemic Influenza Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Pandemic Influenza Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Pandemic Influenza Vaccine Price by Application
        5.3.1 Global Pandemic Influenza Vaccine Price by Application (2017-2022)
        5.3.2 Global Pandemic Influenza Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Pandemic Influenza Vaccine Market Size by Type
        6.1.1 North America Pandemic Influenza Vaccine Sales by Type (2017-2028)
        6.1.2 North America Pandemic Influenza Vaccine Revenue by Type (2017-2028)
    6.2 North America Pandemic Influenza Vaccine Market Size by Application
        6.2.1 North America Pandemic Influenza Vaccine Sales by Application (2017-2028)
        6.2.2 North America Pandemic Influenza Vaccine Revenue by Application (2017-2028)
    6.3 North America Pandemic Influenza Vaccine Market Size by Country
        6.3.1 North America Pandemic Influenza Vaccine Sales by Country (2017-2028)
        6.3.2 North America Pandemic Influenza Vaccine Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Pandemic Influenza Vaccine Market Size by Type
        7.1.1 Europe Pandemic Influenza Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Pandemic Influenza Vaccine Revenue by Type (2017-2028)
    7.2 Europe Pandemic Influenza Vaccine Market Size by Application
        7.2.1 Europe Pandemic Influenza Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Pandemic Influenza Vaccine Revenue by Application (2017-2028)
    7.3 Europe Pandemic Influenza Vaccine Market Size by Country
        7.3.1 Europe Pandemic Influenza Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Pandemic Influenza Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Pandemic Influenza Vaccine Market Size by Type
        8.1.1 Asia Pacific Pandemic Influenza Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Pandemic Influenza Vaccine Market Size by Application
        8.2.1 Asia Pacific Pandemic Influenza Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Pandemic Influenza Vaccine Market Size by Region
        8.3.1 Asia Pacific Pandemic Influenza Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Pandemic Influenza Vaccine Market Size by Type
        9.1.1 Latin America Pandemic Influenza Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Pandemic Influenza Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Pandemic Influenza Vaccine Market Size by Application
        9.2.1 Latin America Pandemic Influenza Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Pandemic Influenza Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Pandemic Influenza Vaccine Market Size by Country
        9.3.1 Latin America Pandemic Influenza Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Pandemic Influenza Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Pandemic Influenza Vaccine Market Size by Type
        10.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Pandemic Influenza Vaccine Market Size by Application
        10.2.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Pandemic Influenza Vaccine Market Size by Country
        10.3.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 CSL
        11.1.1 CSL Corporation Information
        11.1.2 CSL Overview
        11.1.3 CSL Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 CSL Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 CSL Recent Developments
    11.2 GSK
        11.2.1 GSK Corporation Information
        11.2.2 GSK Overview
        11.2.3 GSK Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GSK Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GSK Recent Developments
    11.3 Sanofi Pasteur
        11.3.1 Sanofi Pasteur Corporation Information
        11.3.2 Sanofi Pasteur Overview
        11.3.3 Sanofi Pasteur Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Sanofi Pasteur Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Sanofi Pasteur Recent Developments
    11.4 Mylan
        11.4.1 Mylan Corporation Information
        11.4.2 Mylan Overview
        11.4.3 Mylan Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Mylan Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Mylan Recent Developments
    11.5 AstraZeneca
        11.5.1 AstraZeneca Corporation Information
        11.5.2 AstraZeneca Overview
        11.5.3 AstraZeneca Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 AstraZeneca Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 AstraZeneca Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Corporation Information
        11.6.2 Pfizer Overview
        11.6.3 Pfizer Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Pfizer Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Pfizer Recent Developments
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Corporation Information
        11.7.2 Johnson & Johnson Overview
        11.7.3 Johnson & Johnson Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Johnson & Johnson Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Johnson & Johnson Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Pandemic Influenza Vaccine Industry Chain Analysis
    12.2 Pandemic Influenza Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Pandemic Influenza Vaccine Production Mode & Process
    12.4 Pandemic Influenza Vaccine Sales and Marketing
        12.4.1 Pandemic Influenza Vaccine Sales Channels
        12.4.2 Pandemic Influenza Vaccine Distributors
    12.5 Pandemic Influenza Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Pandemic Influenza Vaccine Industry Trends
    13.2 Pandemic Influenza Vaccine Market Drivers
    13.3 Pandemic Influenza Vaccine Market Challenges
    13.4 Pandemic Influenza Vaccine Market Restraints
14 Key Findings in The Global Pandemic Influenza Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Pandemic Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Whole Virus Vaccines
    Table 3. Major Manufacturers of Split Virus Vaccines
    Table 4. Major Manufacturers of Subunit Vaccines
    Table 5. Global Pandemic Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Pandemic Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Pandemic Influenza Vaccine Sales by Region (2017-2022) & (K Doses)
    Table 8. Global Pandemic Influenza Vaccine Sales Market Share by Region (2017-2022)
    Table 9. Global Pandemic Influenza Vaccine Sales by Region (2023-2028) & (K Doses)
    Table 10. Global Pandemic Influenza Vaccine Sales Market Share by Region (2023-2028)
    Table 11. Global Pandemic Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2017-2022)
    Table 13. Global Pandemic Influenza Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2023-2028)
    Table 15. Global Pandemic Influenza Vaccine Sales by Manufacturers (2017-2022) & (K Doses)
    Table 16. Global Pandemic Influenza Vaccine Sales Share by Manufacturers (2017-2022)
    Table 17. Global Pandemic Influenza Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Pandemic Influenza Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 19. Pandemic Influenza Vaccine Price by Manufacturers (2017-2022) &(USD/Dose)
    Table 20. Global Pandemic Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pandemic Influenza Vaccine as of 2021)
    Table 22. Pandemic Influenza Vaccine Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Pandemic Influenza Vaccine Product Offered
    Table 24. Date of Manufacturers Enter into Pandemic Influenza Vaccine Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Pandemic Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 27. Global Pandemic Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 28. Global Pandemic Influenza Vaccine Sales Share by Type (2017-2022)
    Table 29. Global Pandemic Influenza Vaccine Sales Share by Type (2023-2028)
    Table 30. Global Pandemic Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Pandemic Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Pandemic Influenza Vaccine Revenue Share by Type (2017-2022)
    Table 33. Global Pandemic Influenza Vaccine Revenue Share by Type (2023-2028)
    Table 34. Pandemic Influenza Vaccine Price by Type (2017-2022) & (USD/Dose)
    Table 35. Global Pandemic Influenza Vaccine Price Forecast by Type (2023-2028) & (USD/Dose)
    Table 36. Global Pandemic Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 37. Global Pandemic Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 38. Global Pandemic Influenza Vaccine Sales Share by Application (2017-2022)
    Table 39. Global Pandemic Influenza Vaccine Sales Share by Application (2023-2028)
    Table 40. Global Pandemic Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Pandemic Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Pandemic Influenza Vaccine Revenue Share by Application (2017-2022)
    Table 43. Global Pandemic Influenza Vaccine Revenue Share by Application (2023-2028)
    Table 44. Pandemic Influenza Vaccine Price by Application (2017-2022) & (USD/Dose)
    Table 45. Global Pandemic Influenza Vaccine Price Forecast by Application (2023-2028) & (USD/Dose)
    Table 46. North America Pandemic Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 47. North America Pandemic Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 48. North America Pandemic Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Pandemic Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Pandemic Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 51. North America Pandemic Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 52. North America Pandemic Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Pandemic Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Pandemic Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 55. North America Pandemic Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 56. North America Pandemic Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Pandemic Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Pandemic Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 59. Europe Pandemic Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 60. Europe Pandemic Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Pandemic Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Pandemic Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 63. Europe Pandemic Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 64. Europe Pandemic Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Pandemic Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Pandemic Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 67. Europe Pandemic Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 68. Europe Pandemic Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Pandemic Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Pandemic Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 71. Asia Pacific Pandemic Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 72. Asia Pacific Pandemic Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Pandemic Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Pandemic Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 75. Asia Pacific Pandemic Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 76. Asia Pacific Pandemic Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Pandemic Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2017-2022) & (K Doses)
    Table 79. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2023-2028) & (K Doses)
    Table 80. Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Pandemic Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 83. Latin America Pandemic Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 84. Latin America Pandemic Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Pandemic Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Pandemic Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 87. Latin America Pandemic Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 88. Latin America Pandemic Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Pandemic Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Pandemic Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 91. Latin America Pandemic Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 92. Latin America Pandemic Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Pandemic Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Pandemic Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 95. Middle East and Africa Pandemic Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 96. Middle East and Africa Pandemic Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Pandemic Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Pandemic Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 99. Middle East and Africa Pandemic Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 100. Middle East and Africa Pandemic Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Pandemic Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 103. Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 104. Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 106. CSL Corporation Information
    Table 107. CSL Description and Major Businesses
    Table 108. CSL Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 109. CSL Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. CSL Recent Developments
    Table 111. GSK Corporation Information
    Table 112. GSK Description and Major Businesses
    Table 113. GSK Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 114. GSK Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. GSK Recent Developments
    Table 116. Sanofi Pasteur Corporation Information
    Table 117. Sanofi Pasteur Description and Major Businesses
    Table 118. Sanofi Pasteur Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 119. Sanofi Pasteur Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Sanofi Pasteur Recent Developments
    Table 121. Mylan Corporation Information
    Table 122. Mylan Description and Major Businesses
    Table 123. Mylan Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 124. Mylan Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Mylan Recent Developments
    Table 126. AstraZeneca Corporation Information
    Table 127. AstraZeneca Description and Major Businesses
    Table 128. AstraZeneca Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 129. AstraZeneca Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. AstraZeneca Recent Developments
    Table 131. Pfizer Corporation Information
    Table 132. Pfizer Description and Major Businesses
    Table 133. Pfizer Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 134. Pfizer Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Pfizer Recent Developments
    Table 136. Johnson & Johnson Corporation Information
    Table 137. Johnson & Johnson Description and Major Businesses
    Table 138. Johnson & Johnson Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 139. Johnson & Johnson Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Johnson & Johnson Recent Developments
    Table 141. Key Raw Materials Lists
    Table 142. Raw Materials Key Suppliers Lists
    Table 143. Pandemic Influenza Vaccine Distributors List
    Table 144. Pandemic Influenza Vaccine Customers List
    Table 145. Pandemic Influenza Vaccine Market Trends
    Table 146. Pandemic Influenza Vaccine Market Drivers
    Table 147. Pandemic Influenza Vaccine Market Challenges
    Table 148. Pandemic Influenza Vaccine Market Restraints
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pandemic Influenza Vaccine Product Picture
    Figure 3. Global Pandemic Influenza Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Whole Virus Vaccines Product Picture
    Figure 4. Split Virus Vaccines Product Picture
    Figure 5. Subunit Vaccines Product Picture
    Figure 6. Global Pandemic Influenza Vaccine Market Share by Application in 2021 & 2028
    Figure 7. For Children (6 months to 3 years)
    Figure 8. For Adults and Children over 3 years
    Figure 9. Pandemic Influenza Vaccine Report Years Considered
    Figure 10. Global Pandemic Influenza Vaccine Sales 2017-2028 (K Doses)
    Figure 11. Global Pandemic Influenza Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Pandemic Influenza Vaccine Revenue 2017-2028 (US$ Million)
    Figure 13. Global Pandemic Influenza Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Pandemic Influenza Vaccine Sales Market Share by Region (2017-2022)
    Figure 15. Global Pandemic Influenza Vaccine Sales Market Share by Region (2023-2028)
    Figure 16. North America Pandemic Influenza Vaccine Sales YoY (2017-2028) & (K Doses)
    Figure 17. North America Pandemic Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Pandemic Influenza Vaccine Sales YoY (2017-2028) & (K Doses)
    Figure 19. Europe Pandemic Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Pandemic Influenza Vaccine Sales YoY (2017-2028) & (K Doses)
    Figure 21. Asia-Pacific Pandemic Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Pandemic Influenza Vaccine Sales YoY (2017-2028) & (K Doses)
    Figure 23. Latin America Pandemic Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Pandemic Influenza Vaccine Sales YoY (2017-2028) & (K Doses)
    Figure 25. Middle East & Africa Pandemic Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Pandemic Influenza Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Pandemic Influenza Vaccine in the World: Market Share by Pandemic Influenza Vaccine Revenue in 2021
    Figure 28. Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 30. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 31. Global Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 32. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 33. North America Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 34. North America Pandemic Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 35. North America Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 36. North America Pandemic Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 37. North America Pandemic Influenza Vaccine Sales Share by Country (2017-2028)
    Figure 38. North America Pandemic Influenza Vaccine Revenue Share by Country (2017-2028)
    Figure 39. U.S. Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 42. Europe Pandemic Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 44. Europe Pandemic Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Pandemic Influenza Vaccine Sales Share by Country (2017-2028)
    Figure 46. Europe Pandemic Influenza Vaccine Revenue Share by Country (2017-2028)
    Figure 47. Germany Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. France Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Pandemic Influenza Vaccine Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Pandemic Influenza Vaccine Revenue Share by Region (2017-2028)
    Figure 58. China Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. India Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Pandemic Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Pandemic Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Pandemic Influenza Vaccine Sales Share by Country (2017-2028)
    Figure 73. Latin America Pandemic Influenza Vaccine Revenue Share by Country (2017-2028)
    Figure 74. Mexico Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Pandemic Influenza Vaccine Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Pandemic Influenza Vaccine Revenue Share by Country (2017-2028)
    Figure 83. Turkey Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Pandemic Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 86. Pandemic Influenza Vaccine Value Chain
    Figure 87. Pandemic Influenza Vaccine Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
Frequently Asked Questions
Pandemic Influenza Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pandemic Influenza Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pandemic Influenza Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Papain Powder

Papain Powder market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More

Paraquat Dichloride

Paraquat Dichloride market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More